Yorkshire Biomedical Consultants Association (YBCA) Established in 2004, the company plans and implements the testing of medicines, devices and chemicals prior to their commercialisation. Our consultancy and training services enable pharmaceutical companies to comply with International regulations for safety, quality and effectiveness. Such testing is required to ensure that only safe materials are marketed. The company is an integrated network with a focus on the nonclinical and early clinical phases. Our 10 consultants, combine decades of experience at senior management level, with the expertise to provide cost-effective nonclinical, clinical and product safety assessment guidance leading to product commercialisation or licensing. We select and manage CROs and prepare regulatory submissions, including INDs, NDAs & CTDs and collaborate with clients to evaluate and interpret the safety of existing and potential products.